For the field of drug development, hitting the right target with atomic precision to achieve therapeutic effect remains the core challenge. While traditional R&D pipelines are dependent on ...
A (L398I), B (L509I), and C (T338S), controlling chemo-/regio-selectivity of CYP72A63 for rare licorice triterpenoids production [83]; D, rational design of CYP87D20 with evolutionary information for ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results